| 摘要 |
The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine and a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer, an inventive matrix with extended release of rotigotine suitable for a TTS, an inventive production method for an inventive matrix or a respective TTS comprising rotigotine, as well as uses of the inventive matrix as well as the inventive TTS for the treatment, alleviation and/or prophylaxis of a Parkinson's disease, a Parkinson Plus Syndrome, a depression, a Restless Legs Syndrome, loss of dopaminergic neurons and/or pain. |
